Home Compare IONS vs SNOW
Stock Comparison · Single-driver result

Ionis Pharmaceuticals vs Snowflake: Which Stock Looks Stronger in 2026?

Snowflake leads structurally, with growth as the clearest single gap between the two profiles. Ionis Pharmaceuticals still leads on profitability and stability, which keeps the comparison from looking entirely one-sided. In the market, Ionis Pharmaceuticals carries the stronger setup — intact trend against Snowflake's broken trend. That leaves a split case: the structural lead stays with Snowflake, but the market is not currently confirming it.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The comparison is mainly decided in growth, with the rest of the profile carrying less weight. The overall score gap is 9 points in favour of Snowflake Inc..

Trajectory Similarity
0.62
Moderately similar
Peer-set rank: #10
within Ionis Pharmaceuticals, Inc.'s functional peer set

This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.

The pair shares a valid long-term profile match, but the trajectories are not especially close.

The strongest overlap appears in investment intensity and recent revenue growth.

Similarity drivers
investment intensityrecent revenue growth
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
IONS
Ionis Pharmaceuticals, Inc.
27
Peer-Score
Signal qualityHigh
vs
SNOW
Snowflake Inc.
36
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The clearest separation appears in growth.

Dimension spread: IONS vs SNOW Profitability 17 5 Stability 48 27 Valuation 30 32 Growth 18 100 IONS SNOW
Gap Ranking
#1 Growth +82
#2 Stability +21
#3 Profitability +12
#4 Valuation +2
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for IONS and SNOW Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer IONSSNOW Relative valuation Structural strength

Snowflake Inc. occupies the cheaper side of the setup map, although Ionis Pharmaceuticals, Inc. still holds the stronger structural profile.

Valuation position uses peer-relative valuation score and Forward P/E where available.

Relative Position vs Comparable Companies
Growth
On growth, Snowflake Inc. ranks near the top of the group; Ionis Pharmaceuticals, Inc. sits in the weaker half.
Stability
Ionis Pharmaceuticals, Inc. holds the stronger peer position on stability.
Growth — Dominant Gap
IONS
18
SNOW
100
Gap+82in favour of SNOW

One company is still expanding while the other is contracting, which creates a very wide growth split.

What keeps the gap from being one-sided

On the market side, Ionis Pharmaceuticals carries the stronger trend while Snowflake's trend has broken — the market setup does not confirm the structural advantage.

What this means for the comparison

Growth points more clearly to Snowflake Inc., but stability still runs the other way — keeping the broader result from looking fully settled.

Explore full peer positioning in AssetNext

Break down the IONS vs SNOW comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how IONS and SNOW each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.